2021 Grant Recipients

Daniel L. Abravanel, MD, PhD

Dana-Farber Cancer Institute – Harvard Medical School Metastatic breast cancer (MBC) – breast cancer that has spread to other organs – unfortunately remains incurable. In spite of the increasing number of treatments available that can benefit patients with MBC, the disease eventually develops resistance to each therapy. As such, there is a critical need to […]

Daniel L. Abravanel, MD, PhD Read More »

Rachna Malani MD

Memorial Sloan Kettering Cancer Center A growing problem facing cancer patients today is metastatic disease, especially metastases to the central nervous system (CNS). As things stand today, we have large knowledge gaps in understanding why some breast cancer becomes metastatic to the CNS and how we can effectively identify CNS disease earlier. CNS disease is

Rachna Malani MD Read More »

Douglas Micalizzi MD, PhD

Massachusetts General Hospital – Harvard Medical School Circulating tumor cells (CTCs) are cells that are derived from a tumor, but are isolated from the blood of cancer patients. Only recently has technological advances permitted the isolation and characterization of these rare cells. CTCs offer a snapshot of the invasive cancer cells that give rise to

Douglas Micalizzi MD, PhD Read More »

Scroll to Top
Skip to content